Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study

BackgroundGlycemic variability is associated with the development of diabetic complications through the activation of oxidative stress. This study aimed to evaluate the effects of a dipeptidyl peptidase 4 inhibitor, vildagliptin, or a thiazolidinedione, pioglitazone, on glycemic variability and oxid...

Full description

Bibliographic Details
Main Authors: Nam Hoon Kim, Dong-Lim Kim, Kyeong Jin Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim
Format: Article
Language:English
Published: Academya Publishing Co. 2017-06-01
Series:Endocrinology and Metabolism
Subjects:
Glycemic variability
Dipeptidyl-peptidase IV inhibitors
Thiazolidinediones
Diabetes mellitus, type 2
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-241.pdf

Internet

https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-241.pdf

Similar Items